Skip to content
Home/Companies/MedTech/Blueprint Genetics
BG

Blueprint Genetics

MedTech·Finland·Exited 2020·Held 3yr

Blueprint Genetics is a MedTech company, headquartered in Finland.

Entry
2017
Hold
3yr
Exit
2020
Est. EV
–

Who owns Blueprint Genetics?

Blueprint Genetics was owned by Creathor Ventures through Creathor Venture Fund III (2012 vintage) from 2017 to 2020, exited via Trade Sale.

Buyer identity available on Pro.

Hand-verified · updated 2026-07-03

Creathor Ventures
Investor
Creathor Ventures
Creathor Venture Fund III · 2012 · VC

Key facts

HQFinland
SectorMedTech
StatusAcquired
Exit Type
Trade Sale
Buyer
MOIC
–
Exit Year
2020

More from Creathor Venture Fund III

Other portfolio companies in the same fund.

Allthings Technologies
Active
SoftwareSwitzerland· 2017
EchoRing (R3 Communications)
Active
Deep TechGermany· 2017
CryoTherapeutics
Active
MedTechBelgium· 2016
Digital Insurance Group (Knip)
Active
FintechSwitzerland· 2015
AYOXXA Biosystems
Active
MedTechGermany· 2014
Prostatype Genomics
Exited 2020
MedTechSweden· 2013

More PE-backed in MedTech

Comparable medtech deals from other GPs.

Aflo
Active
Clarendon Fund ManagersUnited Kingdom
Lattice Medical
Active
Finovam GestionFrance
QTAS
Active
OVNI CapitalGermany
Axomove
Active
Go CapitalFrance· 2026
Bioliberty
Active
Scottish National Investment BankUK· 2026
CertHub
Active
Cusp Capital PartnersGermany· 2026
Data refreshed weekly · Sourced from public filings